Skip to main content

ADVERTISEMENT

Partner Approved

Get Eczema Wise During Eczema Awareness Month
Partner Approved
10/16/2020
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better...
10/16/2020
The Dermatologist
Partner Approved
09/11/2020
Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.
Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.
Lynn McKinley-Grant, MD, FAAD...
09/11/2020
The Dermatologist
Tralokinumab: A New Potential for Atopic Dermatitis
Partner Approved
09/11/2020
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy...
09/11/2020
The Dermatologist
Complementary and Alternative Medicines for the Treatment of Atopic Dermatitis
Partner Approved
08/13/2020
Patients often describe seeking alternatives and adjuncts to care for the treatment of their atopic dermatitis. The literature has explored some of the potential in these options.
Patients often describe seeking alternatives and adjuncts to care for the treatment of their atopic dermatitis. The literature has explored some of the potential in these options.
Patients often describe seeking...
08/13/2020
The Dermatologist
Current Considerations in the Treatment of Psoriasis With Phototherapy
Partner Approved
08/13/2020
Phototherapy continues to be a mainstay of psoriasis treatment. Dr Gelfand highlights recommendations for phototherapy administration and patient discussions during the COVID-19 pandemic.
Phototherapy continues to be a mainstay of psoriasis treatment. Dr Gelfand highlights recommendations for phototherapy administration and patient discussions during the COVID-19 pandemic.
Phototherapy continues to be a...
08/13/2020
The Dermatologist
COVID-19: A PA’s Practice in Patience
Partner Approved
08/12/2020
Sarah Patton, MSHS, PA-C
The time away from clinic due to the pandemic has left many with time to contemplate current affairs and their dermatology practice. Sarah Patton, MSHS, PA-C, reflects on how her life and career has changed over the course of 4 months.
The time away from clinic due to the pandemic has left many with time to contemplate current affairs and their dermatology practice. Sarah Patton, MSHS, PA-C, reflects on how her life and career has changed over the course of 4 months.
The time away from clinic due to...
08/12/2020
The Dermatologist
Improving Patient Care: Three Questions With Dr Harper
Partner Approved
08/12/2020
In an interview with The Dermatologist, Julie Harper, MD, discussed ways dermatologists can be more proactive in their treatment of rosacea.
In an interview with The Dermatologist, Julie Harper, MD, discussed ways dermatologists can be more proactive in their treatment of rosacea.
In an interview with The...
08/12/2020
The Dermatologist
Recent Research to Consider  in the Treatment of Atopic Dermatitis and Eczema
Partner Approved
07/15/2020
While much of research is to test the clinical efficacy and safety of drugs, these posters from the American Academy of Dermatology Virtual Meeting Experience 2020 focused on physician decision-making and evaluation, patient characteristics,...
While much of research is to test the clinical efficacy and safety of drugs, these posters from the American Academy of Dermatology Virtual Meeting Experience 2020 focused on physician decision-making and evaluation, patient characteristics,...
While much of research is to...
07/15/2020
The Dermatologist
A Therapeutic Breakthrough in Treatment Through the Inhibition of IL-17A/IL-17F
Partner Approved
07/15/2020
Kristian Reich, MD, PhD, discussed a therapeutic breakthrough with bimekizumab, a novel biologic in development that inhibits IL-17F in addition to IL-17A.
Kristian Reich, MD, PhD, discussed a therapeutic breakthrough with bimekizumab, a novel biologic in development that inhibits IL-17F in addition to IL-17A.
Kristian Reich, MD, PhD,...
07/15/2020
The Dermatologist
Breakthroughs in the Pathogenesis and Phenotypic Presentation of Atopic Dermatitis
Partner Approved
06/11/2020
Atopic dermatitis (AD) is a common chronic inflammatory skin condition that affects 6% to 13% of children and up to 10% of adults in the United States.1,2 This condition commonly emerges in childhood, with up to 85%...
Atopic dermatitis (AD) is a common chronic inflammatory skin condition that affects 6% to 13% of children and up to 10% of adults in the United States.1,2 This condition commonly emerges in childhood, with up to 85%...
...
06/11/2020
The Dermatologist